Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2‐Year Observational Study

AIMS: We evaluate safety and efficacy of autologous bone marrow‐derived mesenchymal stem cells (MSCs) as a potential treatment for neuromyelitis optica spectrum disorder (NMOSD). METHODS: Fifteen patients with NMOSD were recruited. All patients received a single intravenous infusion of 1.0 × 10(8) a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :CNS Neurosci Ther
Главные авторы: Fu, Ying, Yan, Yaping, Qi, Yuan, Yang, Li, Li, Ting, Zhang, Ningnannan, Yu, Chunshui, Su, Lei, Zhang, Rui, Shen, Yi, Lin, Song, Liu, Qiang, Shao, Zonghong, Han, Zhongchao, Shi, Fu‐Dong
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492909/
https://ncbi.nlm.nih.gov/pubmed/27219819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12559
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы